Burcon Nutrascience Corp (BU.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2023 | 03-2022 | 03-2021 | 03-2020 | 03-2019 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 661 | 261 | 123 | 37 | 100 |
| Accounts receivable | -132 | 138 | -6 | -206 | 28 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 40 | -140 |
| Other Working Capital | -238 | -510 | 45 | -4 | -190 |
| Other Operating Activity | -6,306 | -5,803 | -3,195 | -2,606 | -3,944 |
| Operating Cash Flow | $-6,016 | $-5,914 | $-3,033 | $-2,738 | $-4,147 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -360 | -52 | -895 | -101 | -19 |
| Net Acquisitions | N/A | 0 | N/A | -13,000 | N/A |
| Purchase Sale Intangibles | 0 | -1,217 | -1,978 | -1,467 | N/A |
| Other Investing Activity | -4,075 | 37 | 156 | 0 | 0 |
| Investing Cash Flow | $-4,435 | $-1,232 | $-2,717 | $-14,568 | $-19 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 0 | N/A | -1,296 | 1,250 |
| Debt Issued | 5,000 | 0 | N/A | 9,500 | N/A |
| Debt Repayment | -14 | -98 | -90 | -2,509 | N/A |
| Common Stock Issued | 0 | 272 | 5,026 | 25,752 | 0 |
| Other Financing Activity | -90 | 0 | -240 | 399 | -18 |
| Financing Cash Flow | $4,896 | $174 | $4,696 | $31,846 | $1,232 |
| Exchange Rate Effect | 10 | -1 | -4 | 2 | 2 |
| Beginning Cash Position | 7,001 | 13,973 | 15,031 | 489 | 3,421 |
| End Cash Position | 1,457 | 7,001 | 13,973 | 15,031 | 489 |
| Net Cash Flow | $-5,554 | $-6,971 | $-1,054 | $14,540 | $-2,934 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,016 | -5,914 | -3,033 | -2,738 | -4,147 |
| Capital Expenditure | -360 | -1,269 | -2,873 | -1,568 | -19 |
| Free Cash Flow | -6,375 | -7,182 | -5,906 | -4,306 | -4,166 |